FDA OKs Baxalta's drug for von Willebrand bleeding disorder

Tuesday, December 8, 2015 - 16:12 in Health & Medicine

U.S. regulators have approved the first genetically engineered treatment for the most common inherited bleeding disorder, von Willebrand disease....

Read the whole article on AP Health

More from AP Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net